ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,241Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 944

$602K Total Retail Price of All Prescriptions

Rank: 125 out of 944

409 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 12,610 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
PRAVASTATIN SODIUM 824 796 1 17
LISINOPRIL 644 608 2 3
LEVOTHYROXINE SODIUM 590 563 3 2
FUROSEMIDE 520 500 4 6
AMLODIPINE BESYLATE 473 456 5 5
HYDROCHLOROTHIAZIDE 395 362 6 9
ATENOLOL 355 330 7 11
DONEPEZIL HCL 347 347 8 24
WARFARIN SODIUM 316 315 9 7
OMEPRAZOLE 293 288 10 4
POTASSIUM CHLORIDE 281 266 11 15
MIRTAZAPINE 262 260 12 35
METOPROLOL SUCCINATE 206 187 13 14
ATORVASTATIN CALCIUM 203 194 14 13
CARVEDILOL 203 200 14 30
SERTRALINE HCL 194 190 16 23
METOPROLOL TARTRATE 179 167 17 8
ALENDRONATE SODIUM 175 175 18 20
HYDRALAZINE HCL 169 168 19 87
DIOVAN 169 168 19 38
PANTOPRAZOLE SODIUM 151 146 21 34
DIGOXIN 148 134 22 39
METFORMIN HCL 135 114 23 12
NAMENDA 128 128 24 37
FENTANYL 124 124 S2 25 57
HYDROCODONE-ACETAMINOPHEN 123 121 S3 26 10
ALLOPURINOL 107 92 27 22
TAMSULOSIN HCL 104 104 28 27
CLOPIDOGREL 100 100 29 36
FAMOTIDINE 99 93 30 74
CARBIDOPA-LEVODOPA 96 96 31 77
SPIRONOLACTONE 95 95 32 44
GABAPENTIN 89 89 33 18
LOSARTAN POTASSIUM 88 87 34 16
KLOR-CON M20 87 82 35 71
ZOLPIDEM TARTRATE 85 75 36 25
TRAMADOL HCL 84 82 37 21
PREDNISONE 82 76 38 32
PLAVIX 80 80 39 55
POLYETHYLENE GLYCOL 3350 78 72 40 41
QUETIAPINE FUMARATE 68 66 41 69
LIDODERM 68 68 41 73
LANTUS 66 53 43 46
SIMVASTATIN 63 60 44 1
RAMIPRIL 60 55 45 144
IPRATROPIUM-ALBUTEROL 59 59 46 101
OXYCODONE-ACETAMINOPHEN 57 57 S2 47 62
FLUOXETINE HCL 56 56 48 48
NEXIUM 56 56 48 53
GEMFIBROZIL 55 54 50 72
ESCITALOPRAM OXALATE 55 45 50 98
CYMBALTA 54 54 52 75
ISOSORBIDE MONONITRATE ER 54 54 52 52
LATANOPROST 53 53 54 202
PRAZOSIN HCL 51 51 55 369
OXYCODONE HCL 50 35 S2 56 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.